Religare Enterprises Ltd

Religare Enterprises Other Announcement

Religare Enterprises filed CARE Ratings' monitoring agency report for the quarter ended September 30, 2026, on its Rs 1,500 crore preferential warrant issue. The report states proceeds were used per the offer document with no deviation.

Religare Enterprises Earnings Call Transcript: Key Takeaways

Consolidated H1 loss of ₹145 Cr persists; profit rests on Care Health's Ind AS PBT (₹392 Cr, +42%) while NBFC and broking remain small and in build-out.

Religare Enterprises Investor Presentation: Key Takeaways

Religare H1 FY27 consolidated total income Rs4,717 Cr (+19% YoY); PAT loss Rs145 Cr vs Rs54 Cr profit last year. Care GWP growth drives insurance; Finvest lending restarted 6 Nov 2026.

Religare Enterprises Q2 FY27 Results: Net Loss of ₹97.7 Cr

Religare Enterprises Ltd reported revenue from operations of ₹2,381 Cr (+14.6% YoY) and a net loss of ₹97.7 Cr for Q2 FY27.

Key figure

Net loss ₹97.7 Cr

Religare Enterprises Employee Stock Options

Religare Enterprises' NRC granted 25,998 stock options under its ESOP 2019 scheme. Options vest in 5 equal annual tranches at Rs. 230.78 per share exercise price.

Religare Enterprises Business Update

Religare Finvest, a material subsidiary, resumed lending after RBI lifted its Corrective Action Plan. It disbursed its first Loan Against Property on 6 November 2026.

Religare Enterprises Board Meeting Date

Religare Enterprises intimated a board meeting on November 12, 2026 to consider unaudited standalone and consolidated results for the quarter ended September 30, 2026. The trading window stays closed until November 14, 2026.

Religare Enterprises Credit Rating

Religare Enterprises disclosed that CRISIL upgraded credit ratings for its subsidiary Religare Broking's Rs. 500 Crore bank facilities. Long-term rating moved to BBB+/Stable and short-term to A2+.

Religare Enterprises Debt & Borrowing: ₹150 Cr

Care Health Insurance, a material subsidiary of Religare, allotted listed subordinated debentures worth ₹150 Crore at a 10.50% coupon. The debentures mature in 2036, callable after five years.

Value

₹150.0 Cr

Religare Enterprises Management Change

Religare Enterprises appointed Ms. Dipti Jayesh Khandelwal as Company Secretary and Compliance Officer w.e.f. October 31, 2026. She was designated as a Key Managerial Personnel.

Religare Enterprises Other Announcement

Religare Enterprises has filed its quarterly shareholding pattern for the period ending September 30, 2026, as per SEBI Regulation 31(1)(b).